The Impact of Obesity on the Host–Pathogen Interaction with Influenza Viruses – Novel Insights: Narrative Review

Victor Daniel Miron,Anca Cristina Drăgănescu,Daniela Pițigoi,Victoria Aramă,Adrian Streinu-Cercel,Oana Săndulescu

DOI: https://doi.org/10.2147/dmso.s434115

2024-02-14

Diabetes Metabolic Syndrome and Obesity Targets and Therapy

Abstract:Victor Daniel Miron, 1, 2 Anca Cristina Dr&abreveg&abrevenescu, 1, 2 Daniela Pițigoi, 1, 2 Victoria Aram&abreve, 1, 2 Adrian Streinu-Cercel, 1, 2, &ast Oana S&abrevendulescu 1, 2, &ast 1 Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; 2 National Institute for Infectious Diseases "Prof. Dr. Matei Balș", Bucharest, Romania &astThese authors contributed equally to this work Correspondence: Anca Cristina Dr&abreveg&abrevenescu, Department of Pediatrics, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, National Institute for Infectious Diseases "Prof. Dr. Matei Balș", No. 1 Dr. Calistrat Grozovici Street, Bucharest, 021105, Romania, Email After exposure to a viral pathogen, the host–pathogen interaction is essential to determine whether or not infection will ensue, and what the clinical outline of the infection will be. Recent research has shown that the patient with obesity presents a set of particular pathophysiological changes that lead to higher severity of viral infections, and this is particularly true for infection with influenza viruses. Herein, we describe the main metabolic, endocrine, and immune dysregulations that occur in the presence of obesity and their impact on driving intra-host viral diversity, leading to heightened severity and virulence of influenza. We show that obesity is linked to modified responses of both the innate and adaptive immune systems during viral infections, including influenza. Due to chronic inflammation and metabolic, endocrine, and signaling pathway disruptions, individuals with obesity have a suboptimal immune response. This results in longer illness duration, increased virus shedding, higher risk of hospitalization and complications, and greater mortality rates. Additionally, they may have a blunted response to vaccination and a higher likelihood of genetic mutation selection. Understanding the intricate interplay between obesity and viral pathogenesis is crucial for developing efficacious therapeutic approaches and public health policies, particularly in light of the escalating worldwide incidence of obesity. Keywords: influenza, obesity, severity, metabolic syndrome, inflammation After exposure to a viral pathogen, the host-pathogen interaction is essential to determine whether or not infection will ensue, and what the clinical outline of the infection will be. In many instances, in immunocompetent hosts, exposure to a respiratory virus leads to self-limiting non-severe disease. However, certain host-specific factors can alter the host–pathogen interaction and facilitate more severe disease. Recent research has shown that the patient with obesity presents a set of particular pathophysiological changes that lead to higher severity of viral infections, and this is particularly true for infection with influenza viruses. According to the World Health Organization (WHO), it is estimated that, in 2016, 39% of adults worldwide were overweight and 13% were obese. 1 A recent study from Spain shows an even higher prevalence in 2020, 55.8% for overweight status, and 18.7% for obesity in adults. 2 The data is also worrying in children, where up to 17% of those aged between 2 and 19 years are obese, 3 while in Romania, the prevalence of overweight children was reported at 7.5% and that of obese children at 18.5% in 2018. 4 With the high worldwide prevalence of obesity, it has become essential to understand the main metabolic, endocrine, and immune dysregulations that occur during infection with influenza virus, as well as their impact on driving intra-host viral diversity, leading to heightened clinical severity and increased viral virulence. The human host's response to influenza virus infection is not always effective and depends on factors such as age, comorbidities, genetic traits, and immune memory from previous exposure to antigens through vaccination or infection. This creates a complex and dynamic interaction between the host and influenza viruses, where host-specific factors play a crucial role. Increased susceptibility to infection, more severe forms of the disease, or both, can be seen in particular patient groups. As a result, specific risk groups for influenza have been identified by international consensus, for whom priority vaccination is recommended. According to the European Centre for Disease Prevention and Control (ECDC), the groups at risk for severe influenza are older adults (aged 65 years and older) and all persons with comorbidities. These comorbidities include cardiovascular disease, chronic lung disease, diabetes, chronic liver dise -Abstract Truncated-

endocrinology & metabolism